Day: 26 February 2026

Juvenescence Completes Phase 1 Trial of PAI-1 Inhibitor

Juvenescence successfully completes Phase 1 clinical trial of PAI-1 inhibitor and strengthens clinical development leadership PAI-1 Inhibitor (MDI-2517) demonstrates good safety and […]